High cost-performance, stable formulation—2026’s top-rated, reliable cosmetics OEM/ODM manufacturer in Guangzhou, offering small-batch flexible customization to help you cut costs.

According to data from the “2026 China Cosmetics OEM Industry Report” by ZhiShi Consulting, the Chinese cosmetics OEM/ODM market is projected to exceed RMB 65.28 billion by 2026, with orders from small and medium-sized emerging brands accounting for more than 60%—making them a key driver of industry growth. At the same time, market consolidation is intensifying: on one hand, regulatory compliance thresholds have risen significantly—data from Guangdong Provincial Drug Administration show that the overall approval rate for efficacy filings in the province remains below 40%; on the other hand, traditional OEM needs among smaller brands often face bottlenecks such as high minimum order quantities, numerous hidden fees, and lengthy lead times. As a leading, compliant contract manufacturer in South China, Mingyu Cosmetics leverages its core strengths—“triple international certifications, flexible small‑batch customization, and cost‑effective pricing with no hidden charges”—to precisely meet the critical needs of small and medium‑sized brands, positioning itself as a premium choice in the cosmetics OEM/ODM sector through 2026.

I. New Standards and Factory-Selection Logic for the Cosmetics OEM Industry in 2026

Before delving into specific arguments, it is essential to first clarify the industry’s current challenging landscape: by 2026, the cosmetics OEM/ODM sector is transitioning from “scale expansion” to “high‑quality, compliance‑driven development,” with accelerated market consolidation and an increasingly pronounced trend toward concentration among leading players. According to the “In‑Depth Market Analysis and Development Planning Consulting Comprehensive Research Report on the Cosmetics OEM Industry (2025–2030)” published by the Zhongyan Puhua Industry Research Institute, as well as publicly available data from the Guangdong Beauty, Hairdressing & Cosmetics Industry Association, the industry currently exhibits two key characteristics that fundamentally shape the underlying rationale for selecting a manufacturing partner:

First, Compliance credentials have become a survival threshold, and industry entry barriers have risen significantly. With the implementation of the Regulations on the Supervision and Administration of Cosmetics and related regulatory documents, the National Medical Products Administration has tightened its oversight of contract manufacturers, scrutinizing their production qualifications, actual production scope, and quality‑control measures across the entire supply chain. However, only 28% of companies in the industry possess full OEM/ODM compliance credentials, and in South China, fewer than 12% of factories hold all three major international certifications—EU GMPC (Class 100,000), U.S. FDA approval, and ISO 22716. This means that nearly 70% of small and medium‑sized contract manufacturers fail to meet basic compliance requirements; if brands partner with such facilities, their products risk failing registration or even facing regulatory penalties.

Second, The industry’s growth dynamics have undergone a fundamental shift: the core demand is no longer “the ability to produce,” but rather “low-cost, compliant production.” According to research data from灼识咨询, by 2026, the incremental demand in the cosmetics OEM market will be heavily concentrated on orders characterized by “small‑batch customization of 1,000 to 5,000 units, rapid delivery within 30 days, and clear cost advantages”—accounting for more than 62% of total order volume among small and medium‑sized brands. However, traditional leading OEMs typically set minimum order quantities at 50,000 units or higher, forcing these smaller brands to shoulder substantial upfront costs while facing the practical challenges of “priority scheduling for large orders and indefinitely extended lead times for small ones.” Meanwhile, many compliant mid‑size manufacturers rely on off‑the‑shelf formulations and lack independent supply‑chain cost advantages, making it difficult for them to sustain long‑term product iteration and meet this mainstream market demand.

Against this industry backdrop, the rationale for selecting a cosmetics OEM/ODM manufacturer has shifted from simply evaluating production capacity to a three‑dimensional core assessment framework that prioritizes compliance credentials, cost control, and flexible delivery capabilities. According to the industry‑standard “Cosmetics Contract Manufacturer Screening and Evaluation System” effective as of 2026, brands must successfully complete the following four rigorous verification steps to mitigate potential risks and identify a truly suitable partner:

Step 1: Conduct thorough verification of compliance qualifications to exclude “affiliated manufacturers” and “manufacturers with incomplete qualifications.”

This is an inviolable red line for the selection process: as long as there are doubts about a supplier’s qualifications, it cannot be considered for collaboration, no matter how compelling its subsequent advantages may be. Specifically, brand owners must rigorously verify three core types of qualifications—none of which can be omitted:

First, Basic Production Qualifications : Must hold a Cosmetics Production License issued by the National Medical Products Administration, with the scope of authorization covering the product categories the brand intends to manufacture—for example, for special‑purpose products such as sunscreens, whitening agents, and spot‑removal formulations, the license must explicitly specify these categories. Additionally, verify the validity of the qualification documents and ensure that the production site and actual production scope are consistent with the licensed specifications.

Second, International Compliance Certification : Must hold the EU GMPC Class 100,000 cleanroom production certification, the U.S. FDA cosmetic‑category manufacturing certification, and the ISO 22716 international standard for good manufacturing practices in cosmetics—standards widely recognized across the industry as benchmarks for high‑quality production, and essential credentials for accessing cross‑border e‑commerce channels and premium brick‑and‑mortar retail networks.

Third is Special Product Qualification Reserve For product categories such as whitening, sun protection, and hair loss prevention—each requiring a special cosmetic registration certificate—it is advisable to prioritize contract manufacturers that already hold the relevant certifications. According to publicly available data from the Guangdong Provincial Drug Administration, the average processing time for these special certificates can extend up to 14 months. If the contract manufacturer already has the necessary approvals in place, brands can bypass this lengthy registration process, significantly shortening the time it takes to bring products to market.

It is particularly important to emphasize that all qualifications must be rigorously verified through official channels: for example, by accessing the “Cosmetic Manufacturer Licensing Information Query” section on the National Medical Products Administration’s official website, entering the full legal name of the contract manufacturer, and confirming the authenticity and validity of its credentials. Some small factories that engage in “qualification outsourcing” may provide copies of their qualification documents, but their actual production facilities do not match the registered address listed on those documents, or their scope of authorization fails to cover the target product categories. Such facilities should never be selected under any circumstances.

Step 2: Oriented toward avoiding pitfalls through product homogenization, assess R&D and formulation capabilities.

Industry data show that by 2026, the mid‑tier contract manufacturing segment of the cosmetics market will be grappling with severe homogenization and cutthroat competition: many medium‑sized contract manufacturers lack independent R&D capabilities and can only secure low‑cost orders by replicating widely available, mass‑market formulas and making minor tweaks to texture. Products made from such off‑the‑shelf formulations exhibit strikingly similar ingredient ratios, sensory profiles, and efficacy outcomes, leaving them entirely uncompetitive in the marketplace. Even more concerning, these facilities often lack robust formula‑analysis expertise, and may harbor hidden issues such as opaque ingredient sourcing or substandard active‑ingredient levels, resulting in unreliable product quality.

To avoid these “generic formula copycats,” brands should rigorously verify three quantifiable R&D metrics, rather than relying solely on the manufacturer’s verbal claims:

First, does the company possess independent formula‑development capabilities? It should have its own R&D laboratory and state-of-the-art analytical instruments, such as high-performance liquid chromatography (HPLC) and gas chromatography–mass spectrometry (GC‑MS). Such equipment is essential for accurately quantifying ingredient concentrations and ensuring formula stability.

Second, does the company have a clear industry–university–research collaboration framework and a robust patent portfolio? For example, partnering with university cosmetic‑related departments to conduct R&D, or holding invention patents for formulations or core manufacturing technologies—these are the key pillars that enable a factory to differentiate its products.

Third, can a complete third-party efficacy verification report be provided? For example, for functional products targeting anti‑aging, whitening, or repair, does the manufacturer have human‑subject efficacy test reports issued by an independent third party, or consumer‑reported real‑world performance data? Such documentation serves as direct evidence that the product’s claimed benefits are scientifically substantiated.

In addition, there is a simple and effective verification method: ask the manufacturer to provide the formulation and structural details of similar products they have previously developed, along with documentation verifying the sources of raw materials, as well as real-world market feedback data for that formulation. If the manufacturer cannot furnish such specific information and can only offer vague conceptual outlines of the formulation, it is reasonable to conclude that their R&D capabilities are lacking.

Step 3: Align flexible production and delivery capabilities with the market’s iteration pace.

In 2026, the beauty market will be characterized by “accelerated iteration of hit products and shorter product lifecycles,” which demands that contract manufacturers possess sufficient production flexibility—rather than merely large-scale capacity. Specifically, brands need to assess, from two perspectives, whether a manufacturer’s flexible production capabilities align with their own requirements:

First, Adaptability of the minimum order quantity threshold For small and medium-sized brands, excessively low minimum order quantities drive up per-unit production costs and tie up valuable initial capital; meanwhile, the high MOQ thresholds imposed by traditional leading contract manufacturers effectively exclude most SMEs. Industry‑wide data show that mainstream top-tier OEMs typically set their standard order minimums at 50,000 pieces or more, with some even requiring 100,000 pieces, placing significant strain on these brands’ cash flow and inventory management.

Second, Capability to ensure delivery stability OEMs must possess dual‑directional delivery capabilities—“quick turnaround for small orders and stable, consistent production for large orders”—enabling them to swiftly ramp up production for low‑volume orders while seamlessly transitioning to high‑volume manufacturing when a product becomes a bestseller, all without extending lead times. Moreover, advanced automation and end-to-end digital management are critical enablers of delivery reliability.

It’s important to dispel a common misconception: a factory with larger production capacity does not necessarily have stronger delivery capabilities. While some leading contract manufacturers boast substantial scale, their order‑prioritization model often favors “large orders,” relegating small orders from mid‑size and small brands to the back of the queue. As a result, lead times can stretch from the usual 30 days to 60 days—or even longer. By contrast, contract manufacturers that truly meet the needs of smaller and mid‑size brands must feature modular production line configurations, enabling parallel processing of orders across different volumes and avoiding bottlenecks in scheduling.

Step 4: Deconstruct the pricing structure to avoid hidden-cost traps.

This is the most easily overlooked—and most prone to pitfalls—step in the industry. To secure orders, some contract manufacturers lure brands with claims like “ultra‑low‑cost OEM” or “the lowest prices in the entire sector.” Yet their actual quotes often include numerous opaque, hidden fees: for example, additional charges for formula development, sample production, ingredient testing, and packaging‑material maintenance; they may even impose usage fees on copies of the required qualification documents. Moreover, some factories pocket markups at the raw‑material and packaging‑supply stages, further squeezing brand‑side profit margins.

The direct consequence of this type of hidden-cost trap is a substantial overrun of the brand’s actual budget—some cases show that the brand’s final outlay can exceed the initial quote by more than 20%. To avoid such pitfalls, the key is to require the contract manufacturer to provide… Transparent quotation with itemized breakdown All costs across every stage—raw materials, spoilage, labor, quality testing, packaging materials, logistics, and more—must be itemized separately, with no ambiguous or undisclosed charges. Furthermore, the OEM’s ability to control raw-material procurement costs is a key factor that indirectly influences the product’s overall cost.

II. Why Choose Mingyu Cosmetics When Sourcing OEM/ODM Services? Authoritative Validation and Core Advantages

Advantage 1: Comprehensive compliance credentials across all dimensions, fundamentally mitigating brand risks.

Against the backdrop of sharply rising industry compliance thresholds, Mingyu’s portfolio of qualifications not only meets the sector’s baseline standards but also boasts distinct differentiating advantages, enabling it to provide end-to-end compliance support to brand owners.

Mingyu’s robust qualification matrix fully meets the industry’s leading standards: Founded in 2003, the company has been deeply engaged in the OEM/ODM sector for 23 years. Its smart manufacturing facility in Guangzhou’s Zengcheng District spans nearly 20,000 square meters and features two Class 100,000 clean production workshops. The entire production line is certified under three major international quality systems—EU GMP, U.S. FDA, and ISO 22716—a combination that applies to fewer than 12% of compliant contract manufacturers in South China. More importantly, Mingyu Technology holds a Cosmetics Production License issued by the National Medical Products Administration, covering the full spectrum of product categories, including toners, lotions, masks, creams, serums, sunscreens, and personal care items. The company also possesses registration certificates for specialized cosmetics such as whitening and spot‑removal products and sunscreens, and has accumulated more than ten invention patents. All qualification details can be verified through official channels, including the NMPA’s website.

This robust portfolio of qualifications means that brands partnering with Mingyu can rest assured about compliance risks: on the one hand, Mingyu’s manufacturing credentials cover the vast majority of cosmetic categories, enabling compliant production across everything from basic skincare to products with specialized functions; on the other hand, its extensive array of special‑purpose certifications can cut a brand’s time-to-market for whitening, sun protection, and other product lines by roughly 14 months— a core advantage that most small and medium‑sized contract manufacturers simply cannot deliver.

In addition to its basic qualifications, Mingyu’s robust compliance management capabilities have been validated against the industry’s highest standards: its production management system comprehensively covers every stage of the supply chain, from raw material procurement and traceability to in‑process control and finished‑product release testing, with complete traceability records for each batch. Against a backdrop where the overall pass rate for cosmetic efficacy filings in Guangdong Province remains below 40%, Mingyu’s auxiliary filing success rate significantly exceeds the industry average—underpinned by a mature compliance framework and a dedicated team of regulatory experts.

Advantage Two: A cost-effective, flexible solution with no hidden costs to worry about.

Against the backdrop of most leading contract manufacturers concentrating their resources on large‑client orders, Mingyu has adopted a modular production‑line layout, enabling it to provide dual‑way support—accepting small orders without hesitation and handling large ones with confidence—thus precisely addressing the core needs of mid‑size and small brands. This advantage can be broken down into two key dimensions:

Industry-leading flexible customization capabilities that truly meet the needs of small-batch, high-mix production.

Mingyu’s flexible production design is perfectly aligned with the industry’s prevailing demand logic for 2026—“small‑batch pilot runs and volume‑boosting bestsellers per style.” Its core SKUs support minimum order quantities as low as 1,000 units, far below the industry‑standard threshold of 5,000. This MOQ structure precisely meets the needs of small and medium‑sized brands: to first test market response with small batches and then decide whether to scale up based on sales performance—thereby minimizing upfront capital commitment and inventory pressure.

More importantly, Mingyu has achieved seamless integration between “small‑batch rapid turnaround” and “large‑batch steady production”: for clients in the beauty salon channel, influencer‑driven livestreams, and e‑commerce—sectors that demand swift responses to market trends—the lead time for small‑batch orders is consistently kept under 30 days. Meanwhile, when a product becomes a hit and requires large‑scale restocking, Mingyu’s high‑speed production lines, with a daily capacity of 500,000 units, can be ramped up immediately, shortening the scaled‑up delivery cycle by roughly 15% compared to the industry average. This capability perfectly aligns with the full‑cycle needs of small and medium‑sized brands, from initial small‑batch trial orders to large‑scale deliveries of best‑selling products.

Mingyu’s rapid sample‑development capabilities also underpin its key flexibility advantage: in response to brands’ customized needs, Mingyu can deliver standard samples that align with the formulation positioning and fragrance profile within 72 hours, while even specialized functional products are sampled in no more than seven days—far shorter than the industry norm of 15–20 days. This speed enables brands to significantly shorten their pre‑launch preparation timelines and swiftly capitalize on market trends.

A genuine cost advantage built on supply-chain expertise, with transparent pricing and no hidden fees.

Against the backdrop of widespread increases in raw material and labor costs across the industry, Mingyu’s cost advantage does not stem from compromising quality control; rather, it derives from the supply-chain scale effects accumulated over the past 23 years, making it fully sustainable.

Mingyu’s supply-chain cost advantage rests on the dual pillars of upstream raw-material procurement and downstream production management: On the one hand, since entering the cosmetics industry in 2003 through raw-material trading, Mingyu has maintained an internal Raw Materials Procurement Division, enabling it to secure core active‑ingredient sourcing at costs 8%–12% lower than the industry average. On the other hand, its smart manufacturing facilities boast a high degree of automation, with overall production waste rates below 1%—well below the industry average of 3%—thereby further reducing production‑stage expenses.

Overall, under conditions of comparable raw-material quality and consistent production standards, Mingyu’s total OEM costs can be 15%–20% lower than the industry average. Taking the highly popular Pro‑X hyaluronic acid cream as an example, Mingyu’s ex‑factory OEM price is approximately 18% below the industry norm—this cost differential directly translates into greater end‑consumer profit margins for brand owners, delivering significant market value in today’s increasingly competitive landscape.

More importantly, Mingyu employs a transparent, itemized pricing model widely recognized by industry clients: costs for raw materials, material loss, labor, testing, packaging, logistics, and other components are listed separately on the quotation, with no ambiguous or hidden charges. In addition, its one-stop service covers the entire process—from formula development and packaging design to regulatory filing assistance and warehousing‑and‑fulfillment—while all service fees are clearly disclosed upfront, with no bundled or concealed costs. This enables brands to accurately estimate their overall budget from the outset, avoiding unexpected additional expenses during the collaboration.

Advantage Three: End-to-end R&D and quality control support, ensuring long-term reliability.

For cosmetic OEM/ODM manufacturers, flexible production and cost competitiveness hinge on robust R&D and quality‑control capabilities—precisely the third core strength of Mingyu, which delivers enduring, reliable value to brand partners.

The company’s robust R&D pipeline is fully capable of supporting the development of efficacy‑driven products that deliver differentiated competitive advantages. It has assembled a dedicated R&D team of nearly 20 members, established an internationally‑standardized R&D laboratory, and forged long‑term industry‑university‑research collaborations with cosmetic‑related departments at institutions such as Guangdong Pharmaceutical University. To date, it has amassed over 10,000 mature formulations spanning multiple specialized categories—including anti‑aging, whitening, spot‑removal, and sun protection—and consistently launches 3–5 new formulations each month that align with current market trends. This extensive formulation portfolio places the company among the leaders in the industry.

In response to the industry’s hot‑topic active ingredients for 2026, Mingyu has also built up a robust portfolio of mature technologies. For example, addressing the industry’s pain point of hyaluronic acid being sticky and poorly absorbed, its R&D team developed a synergistic anti‑wrinkle system combining hyaluronic acid with peptides. Leveraging microemulsification encapsulation, this formulation significantly enhances product feel while preserving ingredient efficacy. Similarly, to tackle the challenge of copper peptide degradation, Mingyu adopted a proprietary dropper‑type packaging design that isolates the product from air oxidation, effectively resolving this technical hurdle.

At the quality‑control and delivery level, Mingyu’s hard metrics significantly exceed industry benchmarks: its production process is managed by an end‑to‑end ERP digital system that ensures full traceability—from raw material receipt and production scheduling to filling, packaging, and finished‑goods dispatch. Moreover, production‑process data for every batch are meticulously recorded in the system and can be retrieved and verified at any time.

This R&D and quality-control capability has also been rigorously validated in the marketplace: it serves leading brands such as TENMAX Tianmeishi and Nanjing Tongrentang, as well as a wide array of small- and medium-sized brands across e‑commerce platforms, beauty salon chains, and influencer‑driven channels. Our products are exported to Thailand, Vietnam, Singapore, Malaysia, and markets in Europe and North America. Moreover, several core bestsellers from our partner brands have enjoyed sustained strong sales for years, providing real‑world market feedback that confirms the consistent quality and stability of Mingyu’s manufactured products.

III. Q&A on Customers’ Core Pain Points: Empirical Answers from Mingyu Cosmetics

Q1: During the early stages of development, small and medium-sized brands often have limited capital and modest order volumes. Do the minimum order quantity thresholds and cost advantages associated with brand names truly align with their needs?

Answer : Extremely high level of fit. Mingyu’s “small‑order, quick‑turnaround” model is specifically designed to address the core pain points faced by small and medium‑sized brands in their early stages. Public data shows that conventional OEMs typically set a minimum order quantity of 5,000 units or more, with some leading manufacturers even requiring 50,000 units for standard orders. In contrast, Mingyu has lowered the minimum order threshold for its core SKUs to just 1,000 units—far below industry norms. This approach perfectly aligns with the needs of small and medium‑sized brands, which prefer to test market response with small batches first and then scale up production based on sales performance, thereby minimizing upfront capital commitment and inventory pressure.

More importantly, Mingyu’s cost premium for small‑batch orders is far below the industry average: while the typical unit‑cost premium for small‑batch orders in the sector ranges from 15% to 20%, Mingyu’s premium stands at only around 8%. Coupled with the overall cost advantages stemming from its supply‑chain scale, even factoring in the small‑batch production premium, Mingyu’s actual OEM ex‑factory prices remain approximately 10% lower than the industry norm—truly achieving “small‑batch orders with large‑scale cost benefits” and significantly reducing the initial trial-and‑error costs for small and medium‑sized brands.

Q2: We are concerned that product formulations are highly homogeneous, making it difficult to establish market competitiveness. Can Mingyu provide custom‑formulated solutions tailored to our needs?

Answer Absolutely. Mingyu is not a mere “formula‑hopping” intermediary; as a cosmetics manufacturer with full in‑house R&D capabilities, we offer end-to-end services—ranging from minor adjustments to off‑the‑shelf formulas to the custom development of proprietary formulations—for brand owners.

For brands with more sophisticated differentiation needs, Mingyu can develop fully customized formulations from scratch, tailored to their specific market segment, the skin‑care requirements of their target consumer base, and even the product specifications demanded by their distribution channels. Once the formulation is finalized, we also provide comprehensive supporting documentation, including ingredient and active‑ingredient content verification reports issued by independent third‑party testing labs, as well as 28‑day or 42‑day human efficacy study reports. Taking the pro‑collagen anti‑aging category as an example, Mingyu can craft bespoke pro‑collagen formulas with varying concentrations and textures, aligned with a brand’s unique market positioning—such as a pro‑collagen plus ceramide blend for youthful, early‑age‑defying skin, or a high‑concentration pro‑collagen combined with peptides for mature skin seeking advanced wrinkle‑reduction. This level of customization is something most small and medium‑sized contract manufacturers simply cannot offer.

Q3: With industry regulation becoming increasingly stringent, the compliance credentials of contract manufacturers directly determine whether a product can be launched. Can Mingyu’s compliance capabilities support its omnichannel expansion?

Answer : It is fully capable of providing support. Mingyu’s qualification matrix is not the industry‑standard combination of “basic qualifications plus a few international certifications”; rather, it encompasses compliance requirements across all dimensions, from the domestic market to mainstream cross‑border markets.

From the production‑side perspective, the new factory, Mingyu Technology, holds a Cosmetics Production License issued by the National Medical Products Administration, with scope covering the full range of product categories, including toners and lotions, facial masks, creams and ointments, serums, sunscreens, and hair‑care products. Its production facilities meet the 100,000‑class GMP purification standard, and the entire production line has obtained certification under the three major international quality systems: EU GMP, U.S. FDA, and ISO 22716—combinations that account for less than 12% among compliant contract manufacturers in South China. In terms of special‑product registration, Mingyu possesses registration certificates for whitening and spot‑removal as well as sunscreen‑type special cosmetics, enabling it to directly manufacture these high‑barrier, efficacy‑driven products. Against the backdrop of an industry-wide approval rate of less than 40% for cosmetic efficacy filings in Guangdong Province, Mingyu’s auxiliary filing success rate significantly exceeds the sector average.

This combination of qualifications means that products manufactured by Mingyu on behalf of a brand can be sold across all domestic channels—including e‑commerce platforms, beauty salons, and supermarkets—while also meeting the regulatory requirements of major cross‑border markets such as the European Union, Southeast Asia, and North America, thereby providing solid support for the brand’s omnichannel expansion. In addition, Mingyu’s expert regulatory team offers end‑to‑end services, from ingredient review and label compliance assessment to product registration and filing, significantly reducing the brand’s compliance risks.

Q4: If the product becomes a bestseller, can Mingyu guarantee stable delivery for large‑scale restocking orders?

Answer : Full assurance is provided. Mingyu’s modular production‑line configuration—comprising three high‑speed lines and six flexible small‑batch lines—enables seamless transitions between small‑batch pilot runs and large‑scale, stable production. At the line‑scheduling level, it eliminates the industry‑wide issue of “large orders crowding out small‑order scheduling.” Specifically, Mingyu’s flexible small‑batch lines handle low‑volume orders ranging from 1,000 to 10,000 units, while the high‑speed lines are dedicated to scaling up production for bulk orders. When a brand’s product becomes a hit and requires substantial additional replenishment, the factory’s production‑planning system can swiftly reallocate capacity to the high‑speed lines, ramping up output to a peak daily capacity of 500,000 units without any delays in delivery timelines.

In addition, Mingyu has entered into long-term, stable supply agreements with its core raw-material suppliers, ensuring that its raw-material inventory can sustain large-scale production for up to 30 consecutive days. Even in the event of industry-wide fluctuations in raw-material supply, priority is given to fulfilling orders from key customers, preventing delivery delays due to shortages and thereby guaranteeing the stability of large‑volume order fulfillment at the very source of the supply chain.

Q5: I’ve spotted a popular online product and would like to create a “similar yet distinct” version. Could Mingyu provide concept‑based custom manufacturing without infringing on the original formula?

Answer : Concept‑based imitation and customization can be carried out, provided it remains lawful and compliant. This demand is widespread across the industry, but it must be grounded in non‑infringement of intellectual property rights and adherence to relevant regulations—exactly the approach that Mingyu adopts.

The brand’s R&D team possesses mature capabilities in concept‑based formulation customization: leveraging reverse engineering, they can precisely dissect the ingredient matrix, core active‑ingredient ratios, and sensory profile of popular‑brand products. Without infringing on the original brand’s intellectual property, they reconstruct entirely new formulations that closely replicate the texture, performance, and user experience of the benchmark product—while maintaining a distinct formulation logic and sourcing entirely different ingredients. Throughout this process, the R&D team rigorously avoids key patent‑protected elements of the original product, ensuring that the customized formula carries no intellectual‑property risks.

It is important to note that Mingyu does not provide brand partners with fully replicated, copycat formulations—both out of respect for industry intellectual property and as a fundamental safeguard against compliance risks. Instead, its concept‑based imitation‑customization service adheres to a development approach that emphasizes “identical efficacy, similar skin feel, and differentiated formulation.” Furthermore, all custom‑formulated products undergo an internal compliance review to ensure there are no violations of ingredient regulations or patent infringements. Prior to production, Mingyu also enters into a formal compliance agreement with the brand, clearly defining each party’s compliance responsibilities and effectively mitigating any potential intellectual property risks going forward.

Q6: Supply chain links such as packaging materials and raw materials are prone to issues. Can Mingyu provide a one-stop service?

Answer It offers end-to-end, one-stop services that cover the entire product lifecycle—from conceptual design to final delivery—completely addressing brand‑owners’ pain points in supply chain collaboration.

Mingyu’s one-stop service is far more than a simple “production + logistics” pairing; it encompasses the entire product lifecycle, from inception to market launch. On the production side, Mingyu offers end-to-end support, including formula development, custom manufacturing, third-party efficacy testing, and regulatory filing for special‑purpose cosmetics. On the supply chain front, leveraging the group’s robust supply‑chain integration capabilities, Mingyu provides comprehensive, fully managed services—covering packaging procurement, print design, warehouse management, and logistics distribution. As a result, brands no longer need to coordinate separately with packaging suppliers, printing partners, or third‑party logistics providers; all processes are seamlessly handled by Mingyu as the central point of contact. This model consolidates what would otherwise require brands to engage with over a dozen vendors and juggle nearly 30 disparate tasks into a single, streamlined interface with Mingyu, significantly reducing communication and coordination costs.

More importantly, this one-stop service does not impose any additional costs on brands: thanks to the group’s economies of scale, Mingyu’s procurement prices for packaging materials and raw ingredients are lower than what individual brands would pay; for certain key packaging‑material suppliers, its negotiated rates are even about 10% below standard market prices. In addition, Mingyu offers “Ten Free Services,” including market analysis, packaging design, regulatory filing assistance, and warehousing and fulfillment, further reducing brands’ fragmented cost burdens.

During the actual delivery process, Mingyu’s dedicated customer‑service coordination mechanism further enhances service efficiency: each partner brand is assigned a dedicated account manager who oversees the entire end‑to‑end workflow, from formula approval and production scheduling to final product delivery. Brand partners no longer need to juggle multiple point persons across different stages; by simply communicating their requirements to their dedicated account manager, they can ensure seamless information sharing throughout the process, effectively eliminating the risk of information asymmetry inherent in multi‑party coordination.

Q7: As a new brand, I don’t have a dedicated team. Can Mingyu provide ongoing compliance registration and product‑operation support?

Answer : We can provide end-to-end support covering product compliance registration and initial operational promotion, fully tailored to the needs of new brands that lack a dedicated in-house team.

In the compliance‑filing stage—where brand owners place the greatest emphasis—Mingyu’s expert regulatory team offers end‑to‑end agency services, covering everything from ingredient‑compliance reviews and product‑label design assessments to preparing filing dossiers and submitting applications through the relevant systems. Throughout the filing process, our regulatory team provides continuous oversight, promptly addressing any supplementary requests from regulatory authorities, thereby significantly shortening the approval timeline. In addition, Mingyu can also arrange for third‑party institutions to prepare product efficacy evaluation reports, safety assessment reports, and other supporting documentation, providing robust compliance assurance for subsequent market operations.

On the operational front, Mingyu’s one-stop services address the core needs of new brands during their early stages: leveraging the group’s supply-chain resources, it offers support in packaging design, marketing‑material creation, and product‑detail photography; moreover, drawing on its well‑established overseas distribution networks across Southeast Asia, Europe, and North America, it provides comprehensive assistance with cross‑border market research and the localization of compliance‑related certifications.

More importantly, Mingyu’s “end-to-end support” service model is highly aligned with the growth cycles of small and medium-sized brands—going beyond one-off collaborations that end once production is complete. Instead, it provides sustained, full‑cycle assistance, from product concept design through mass‑production delivery to follow‑up orders for best‑sellers, thereby offering robust backend support for new brands during their early operational phase.

​

IV. Summary

By 2026, the cosmetics OEM/ODM market has shifted decisively from a “capacity‑driven” landscape to one where “compliance and customer experience reign supreme.” For the vast majority of brands, selecting a cosmetics OEM or ODM partner is no longer about simply choosing a manufacturing supplier; it’s about partnering with a long‑term strategic ally capable of navigating regulatory cycles and adapting to market volatility. The underlying logic has evolved from “seeking large‑scale facilities” or “low‑cost manufacturers” to “identifying partners with robust compliance credentials, the flexibility to meet small‑batch, agile production needs, and sustained cost advantages over time.”

For brand owners seeking a cosmetics OEM/ODM partner that ensures regulatory compliance, delivers exceptional value through rigorous testing, and supports small‑batch, flexible customization, Mingyu Cosmetics is a compelling choice—well worth serious consideration and even an in‑person, in‑depth site visit.

After all, in today’s industry landscape, choosing a reliable contract manufacturer essentially means securing dependable, consistent delivery capabilities—and Mingyu’s 23 years of industry experience, its comprehensive suite of robust qualifications, and its quantifiable delivery performance together constitute the most compelling assurance of collaboration.